Keratoconus is a rare disease that arises in childhood and is characterized by compulsive eye rubbing and changing prescription. Rubbing your eyes harder and harder. Routine screen use, dry ...

Ophthalmologist Hakam Ghabra shares what every parent needs to know about this rare eye disease and what to do to prevent ...

Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.

This next-generation corneal cross-linking iLink therapy is intended for the treatment of keratoconus, a progressive and vision-threatening corneal disease. .In October 2024, Glaukos intends to ...

Parekh, MD, MBA, chief commercial officer of Nordic Pharma, Eye Care U.S., discusses the benefits of Lacrifill for dry eye disease ... ASPENS is a society of cornea, cataract and refractive ...